Kenvue Inc.’s early months as a standalone company, after Johnson & Johnson sold its controlling stake, haven’t meant it’s standing alone in the consumer health segment and isn’t working with competitors to expand its business.
Neither is Kenvue standing apart from its competitors concerning headwinds from foreign exchange rates, the firm reported 26 October with...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?